MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Is an integrated Parkinson’s Dementia Service the way forward?

A. Rafeeq, C. Thomas, B. Mohamed, J. Adenwalla, S. Page, R. Lewis-Morton, S. Mahon, T. Williams (Cardiff, United Kingdom)

Meeting: 2023 International Congress

Abstract Number: 386

Keywords: Dementia, Memory disorders, Parkinson’s

Category: Parkinson's Disease: Cognitive functions

Objective: To illustrate the role of a single team in managing all facets of Parkinson’s

Background: The Cardiff and Vale Parkinson’s service is an integrated, multidisciplinary service located in South Wales, UK. The clinic provides support and input from initial diagnosis through to end of life care, undertaking comprehensive, specialist assessments for patients. Traditional care models have focused on physical disease, with neuropsychiatric symptoms often requiring input from other (e.g. Mental Health) teams to manage even the less- complex symptoms of dementia. The Cardiff team aims to manage both physical and neuropsychiatric symptoms via pharmacologic and non-pharmacologic means.

Method: From our total clinic population, a cohort of 425 people with established Idiopathic Parkinson’s who were subsequently diagnosed with Parkinson’s dementia (PDD) in the decade 2013-2023 was identified.  From this cohort we further assessed a sample of 50 people (56% male, 44% female, mean age 75 years) for advanced demographics, disease duration, presenting dementia features and the diagnostic method used.

Results: From our database of 3668 clinic patients, 425 people with PDD were identified.  76% people with PDD (n=325) were prescribed acetylcholinesterase inhibitors. Subgroup analysis (n=50) demonstrated that cognition was assessed by a range of tests: Addenbrookes Cognitive Examination (60%), Montreal Cognitive Assessment (22%), clinical opinion alone (16%) or Rowland Universal Dementia Assessment Scale (2%).  Neuroimaging was undertaken in 25/50 (50%) patients, predominantly to exclude other pathologies.  The mean time from PD diagnosis to PDD diagnosis was 6.5 years, and survival from PDD was a mean of 3 years. The care of all patients was coordinated by the Parkinson’s team including prescribing of “dementia” medications.

Conclusion: When cognitive impairment or dementia develops in Parkinson’s, care provision by the same team ensures continuity for People with Parkinson’s (PwP) and their families or carers.  PwP live for an average of 3 years post-dementia diagnosis and so joint training in both ‘traditional’ Parkinson’s care, and diagnosis and management of dementia allows for a truly holistic approach in managing the complex interplay between motor, non-motor and neuropsychiatric features that manifests later in this condition.

To cite this abstract in AMA style:

A. Rafeeq, C. Thomas, B. Mohamed, J. Adenwalla, S. Page, R. Lewis-Morton, S. Mahon, T. Williams. Is an integrated Parkinson’s Dementia Service the way forward? [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/is-an-integrated-parkinsons-dementia-service-the-way-forward/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/is-an-integrated-parkinsons-dementia-service-the-way-forward/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley